← Back to headlines
AbbVie's Allergan Aesthetics Receives FDA Approval for Skinvive by Juvederm
AbbVie's Allergan Aesthetics division has secured FDA approval for its new product, Skinvive by Juvederm, expanding its portfolio of aesthetic treatments.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Apple Approves Compensation Packages for New CEO Ternus and Chair Cook
29m ago
Renewed US-Iran Strikes Spark Oil Surge and Market Turmoil
33m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
2h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
3h ago